MentionFox
Home › 5%+ stakes › Manufacturing (industry group 38), latest filing in May 2026
5%+ stakes

Manufacturing (industry group 38), latest filing in May 2026

10 companies with 5%+ holders, every filing linked: Badger Meter Inc, Cooper Companies, Inc., Envista Holdings Corp, Glaukos Corp, Imricor Medical Systems, Inc., Plus Therapeutics, Inc. and more. Each section is the company's full record from its filings, newest filings first within each section.

10 companies with 5%+ holders on this page (Manufacturing (industry group 38), latest filing in May 2026), each linked to its filing, starting with Badger Meter Inc, Cooper Companies, Inc., Envista Holdings Corp. Free check on any of them: https://mentionfox.com/check

On this page

Badger Meter Inc

At 5% or more3
Filings5
Latest filing2026-05-12

Badger Meter Inc has 5 Schedule 13D or 13G filings on record since 2026-01-30. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Portfolio Management8.48%2,477,453SCHEDULE 13G, 2026-04-282026-03-31
Vanguard Capital Management5.23%1,526,620SCHEDULE 13G, 2026-04-292026-03-31
State Street Corporation5.2%1,524,970SCHEDULE 13G, 2026-05-122026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Portfolio Management25,80202,477,4530SCHEDULE 13G, 2026-04-28
Vanguard Capital Management225,00001,526,6200SCHEDULE 13G, 2026-04-29
State Street Corporation01,429,91801,524,970SCHEDULE 13G, 2026-05-12
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies Badger Meter Inc by CUSIP 056525108 and gives its principal executive office as 4545 WEST BROWN DEER ROAD, PO BOX 245036, MILWAUKEE, WI 53223 (SCHEDULE 13G, 2026-05-12).

FiledHolderPercentFiling
2026-01-30The Vanguard Group13.5%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-28Vanguard Portfolio Management8.48%SCHEDULE 13G
2026-04-29Vanguard Capital Management5.23%SCHEDULE 13G
2026-05-12State Street Corporation5.2%SCHEDULE 13G

Cooper Companies, Inc.

At 5% or more1
Filings4
Latest filing2026-05-14

Cooper Companies, Inc. has 4 Schedule 13D or 13G filings on record since 2025-11-13. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management7.51%14,664,697SCHEDULE 13G, 2026-04-292026-03-31
Capital World Investors4%7,834,830SCHEDULE 13G/A, 2026-05-142026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management1,945,868014,664,6970SCHEDULE 13G, 2026-04-29
Capital World Investors7,775,38907,834,8300SCHEDULE 13G/A, 2026-05-14
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies Cooper Companies, Inc. by CUSIP 216648501 and gives its principal executive office as 6101 BOLLINGER CANYON ROAD, SUITE 500, SAN RAMON (SCHEDULE 13G/A, 2026-05-14).

FiledHolderPercentFiling
2025-11-13Capital World Investors5.5%SCHEDULE 13G
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Capital Management7.51%SCHEDULE 13G
2026-05-14Capital World Investors4%SCHEDULE 13G/A
DateRecordFigureOur pageSource
October 27, 2026Leadership change: Walter M. Rosebrough appointed, Executive Chair, and 1 more—Leadership changesSource
May 4, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

Envista Holdings Corp

At 5% or more2
Filings8
Latest filing2026-05-11

Envista Holdings Corp has 8 Schedule 13D or 13G filings on record since 2025-07-15. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Dimensional Fund Advisors LP5.4%9,170,511SCHEDULE 13G, 2025-07-152025-06-30
Vanguard Capital Management5.23%8,574,557SCHEDULE 13G, 2026-04-292026-03-31
Franklin Mutual Advisers, LLC4.85%7,985,856SCHEDULE 13G/A, 2026-01-292025-12-31
Harris Associates L P4.6%7,812,256SCHEDULE 13G/A, 2025-08-142025-06-30
Morgan Stanley4.4%7,094,584SCHEDULE 13G/A, 2026-05-112026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management1,255,97608,574,5570SCHEDULE 13G, 2026-04-29
Franklin Mutual Advisers, LLC7,583,97807,985,8560SCHEDULE 13G/A, 2026-01-29
Morgan Stanley06,240,26406,729,715SCHEDULE 13G/A, 2026-05-11
Atlanta Capital Management Company, LLC05,229,56105,640,826SCHEDULE 13G/A, 2026-05-11
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies Envista Holdings Corp by CUSIP 29415F104 and gives its principal executive office as 200 S. KRAEMER BLVD., BLDG. E, BREA, CA 92821 (SCHEDULE 13G/A, 2026-05-11).

FiledHolderPercentFiling
2025-07-15Dimensional Fund Advisors LP5.4%SCHEDULE 13G
2025-08-05Franklin Mutual Advisers, LLC5.3%SCHEDULE 13G
2025-08-14Harris Associates L P4.6%SCHEDULE 13G/A
2025-11-07Morgan Stanley6.1%SCHEDULE 13G/A
2026-01-29Franklin Mutual Advisers, LLC4.85%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Capital Management5.23%SCHEDULE 13G
2026-05-11Morgan Stanley4.4%SCHEDULE 13G/A
DateRecordFigureOur pageSource
June 3, 2026Leadership change: Faez Kaabi departs, Chief Accounting Officer, and 1 more—Leadership changesSource

Glaukos Corp

At 5% or more4
Filings9
Latest filing2026-05-15

Glaukos Corp has 9 Schedule 13D or 13G filings on record since 2025-08-07. 4 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Janus Henderson Group Plc9.2%5,348,395SCHEDULE 13G/A, 2026-05-152026-03-31
Primecap Management Co5.88%3,376,928SCHEDULE 13G, 2026-02-112025-12-31
Vanguard Portfolio Management5.6%3,256,962SCHEDULE 13G, 2026-04-292026-03-31
Vanguard Capital Management5.07%2,947,047SCHEDULE 13G, 2026-04-292026-03-31
Fmr LLC4.5%2,561,428SCHEDULE 13G/A, 2025-08-072025-07-31
Wellington Management Group LLP0.8%486,824SCHEDULE 13G/A, 2026-02-102025-12-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Janus Henderson Group Plc05,348,39505,348,395SCHEDULE 13G/A, 2026-05-15
Vanguard Portfolio Management48,59903,256,9620SCHEDULE 13G, 2026-04-29
Vanguard Capital Management438,27602,947,0470SCHEDULE 13G, 2026-04-29
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies Glaukos Corp by CUSIP 377322102 and gives its principal executive office as 1 GLAUKOS WAY, ALISO VIEJO, CA 92656 (SCHEDULE 13G/A, 2026-05-15).

FiledHolderPercentFiling
2025-08-07Fmr LLC4.5%SCHEDULE 13G/A
2025-08-12Wellington Management Group LLP5.7%SCHEDULE 13G
2026-02-10Wellington Management Group LLP0.8%SCHEDULE 13G/A
2026-02-11Primecap Management Co5.88%SCHEDULE 13G
2026-02-17Janus Henderson Group Plc5.3%SCHEDULE 13G
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Capital Management5.07%SCHEDULE 13G
2026-04-29Vanguard Portfolio Management5.6%SCHEDULE 13G
2026-05-15Janus Henderson Group Plc9.2%SCHEDULE 13G/A

Imricor Medical Systems, Inc.

At 5% or more1
Filings1
Latest filing2026-05-20

Imricor Medical Systems, Inc. has 1 Schedule 13D or 13G filing on record since 2026-05-20. 1 holder's latest filing reports 5% or more of class a common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
K.A.H.R. Foundation8.89%31,023,094SCHEDULE 13G, 2026-05-202026-05-18
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
K.A.H.R. Foundation31,023,094031,023,0940SCHEDULE 13G, 2026-05-20

The latest filing identifies Imricor Medical Systems, Inc. by CUSIP 000000000 and gives its principal executive office as 400 Gateway Blvd., Burnsville, MN 55337 (SCHEDULE 13G, 2026-05-20).

FiledHolderPercentFiling
2026-05-20K.A.H.R. Foundation8.89%SCHEDULE 13G

Plus Therapeutics, Inc.

At 5% or more1
Filings5
Latest filing2026-05-15

Plus Therapeutics, Inc. has 5 Schedule 13D or 13G filings on record since 2025-07-29. 1 holder's latest filing reports 5% or more of common stock, $0.001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Highbridge Capital Management, LLC7.1%13,157,894SCHEDULE 13G, 2026-05-152026-03-31
CVI Investments, Inc.4.9%9,009,978SCHEDULE 13G/A, 2026-05-152026-03-31
Orin Hirschman3.9%1,283,681SCHEDULE 13G/A, 2025-07-292025-06-30
S.H.N. Financial Investments Ltd.1.51%1,500,000SCHEDULE 13G/A, 2025-08-142025-08-14
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Highbridge Capital Management, LLC13,157,894013,157,8940SCHEDULE 13G, 2026-05-15
CVI Investments, Inc.09,009,97809,009,978SCHEDULE 13G/A, 2026-05-15
Heights Capital Management, Inc.09,009,97809,009,978SCHEDULE 13G/A, 2026-05-15
S.H.N. Financial Investments Ltd.1,500,00001,500,0000SCHEDULE 13G/A, 2025-08-14

The latest filing identifies Plus Therapeutics, Inc. by CUSIP 72941H806 and gives its principal executive office as 6420 Levit Green Boulevard, Suite 310, Houston, TX 77021 (SCHEDULE 13G, 2026-05-15).

FiledHolderPercentFiling
2025-07-29Orin Hirschman3.9%SCHEDULE 13G/A
2025-08-14S.H.N. Financial Investments Ltd.1.51%SCHEDULE 13G/A
2026-01-22CVI Investments, Inc.6.9%SCHEDULE 13G
2026-05-15Highbridge Capital Management, LLC7.1%SCHEDULE 13G
2026-05-15CVI Investments, Inc.4.9%SCHEDULE 13G/A
DateRecordFigureOur pageSource
September 18, 2026Form D, private offering$3M soldForm D pageSource
April 9, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

Radnostix Inc

At 5% or more1
Filings1
Latest filing2026-05-14

Radnostix Inc has 1 Schedule 13D or 13G filing on record since 2026-05-14. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Kennerman Associates, Inc.42.4%237,489,559SCHEDULE 13G, 2026-05-142025-12-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Kennerman Associates, Inc.000237,489,559SCHEDULE 13G, 2026-05-14
Grosso Christopher G60,542,9595,102,5815,000,00055,542,959SCHEDULE 13G, 2026-05-14

The latest filing identifies Radnostix Inc by CUSIP 45972C102 and gives its principal executive office as 4137 COMMERCE CIRCLE, IDAHO FALLS, ID 83401 (SCHEDULE 13G, 2026-05-14).

FiledHolderPercentFiling
2026-05-14Kennerman Associates, Inc.42.4%SCHEDULE 13G

SS Innovations International, Inc.

At 5% or more1
Filings1
Latest filing2026-05-04

SS Innovations International, Inc. has 1 Schedule 13D or 13G filing on record since 2026-05-04. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Sudhir Srivastava, M.D.55.8%114,490,054SCHEDULE 13G/A, 2026-05-042026-03-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Sudhir Srivastava, M.D.114,490,0540114,490,0540SCHEDULE 13G/A, 2026-05-04
Sushruta PVT LTD109,585,7670109,585,7670SCHEDULE 13G/A, 2026-05-04

The latest filing identifies SS Innovations International, Inc. by CUSIP 05453U203 and gives its principal executive office as 1600 SE 15th Street, #512 Fort, Lauderdale, FL 33316 (SCHEDULE 13G/A, 2026-05-04).

(1) Sudhir Srivastava, M.D. - 55.8% (2) Sushruta PVT LTD - 54.7%. All calculations of percentage ownership herein are based upon an aggregate of 200,231,535 shares of common stock outstanding as of March 9, 2026, as reported in the issuer's Amended Annual Report on Form 10-K/A for the year ended December 31, 2025.Sudhir Srivastava, M.D., SCHEDULE 13G/A, 2026-05-04
FiledHolderPercentFiling
2026-05-04Sudhir Srivastava, M.D.55.8%SCHEDULE 13G/A
DateRecordFigureOur pageSource
May 26, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
March 19, 2026Form D, private offering$18.62M soldForm D pageSource

Steris Plc

At 5% or more3
Filings5
Latest filing2026-05-12

Steris Plc has 5 Schedule 13D or 13G filings on record since 2025-11-04. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Layoffs on record: 1 filing or notice, latest 2026-08-05 (layoff filings and notices).

HolderPercentSharesLatestEvent date
Vanguard Capital Management7.48%7,340,236SCHEDULE 13G, 2026-04-302026-03-31
State Street Corporation5.1%4,995,259SCHEDULE 13G, 2026-05-122026-03-31
Vanguard Portfolio Management5.05%4,962,018SCHEDULE 13G, 2026-04-292026-03-31
Massachusetts Financial Services Company4.9%4,846,124SCHEDULE 13G/A, 2025-11-042025-09-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management973,85807,340,2360SCHEDULE 13G, 2026-04-30
State Street Corporation03,198,31004,992,076SCHEDULE 13G, 2026-05-12
Vanguard Portfolio Management11,97804,962,0180SCHEDULE 13G, 2026-04-29
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Steris Plc by CUSIP G8473T100 and gives its principal executive office as 5960 HEISLEY ROAD, MENTOR, OH 44060 (SCHEDULE 13G, 2026-05-12).

FiledHolderPercentFiling
2025-11-04Massachusetts Financial Services Company4.9%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management5.05%SCHEDULE 13G
2026-04-30Vanguard Capital Management7.48%SCHEDULE 13G
2026-05-12State Street Corporation5.1%SCHEDULE 13G
DateRecordFigureOur pageSource
August 6, 2026Leadership change: Pierre Boulud appointed—Leadership changesSource
May 7, 2026Leadership change: Richard C. Breeden departs, and 1 more—Leadership changesSource

Waters Corp

At 5% or more2
Filings7
Latest filing2026-05-15

Waters Corp has 7 Schedule 13D or 13G filings on record since 2025-08-13. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.7.8%7,637,586SCHEDULE 13G/A, 2026-04-242026-03-31
Vanguard Capital Management7.49%7,351,785SCHEDULE 13G, 2026-04-302026-03-31
Fundsmith LLP4.4%4,308,930SCHEDULE 13G/A, 2026-05-152026-03-31
AllianceBernstein L.P.3.5%2,084,443SCHEDULE 13G/A, 2025-11-142025-09-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.6,999,24707,637,5860SCHEDULE 13G/A, 2026-04-24
Vanguard Capital Management973,01007,351,7850SCHEDULE 13G, 2026-04-30
Fundsmith LLP4,294,85004,308,9300SCHEDULE 13G/A, 2026-05-15
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Waters Corp by CUSIP 941848103 and gives its principal executive office as 34 Maple Street, Milford, MA 01757 (SCHEDULE 13G/A, 2026-05-15).

FiledHolderPercentFiling
2025-08-13AllianceBernstein L.P.6.8%SCHEDULE 13G/A
2025-10-31The Vanguard Group12.86%SCHEDULE 13G/A
2025-11-14AllianceBernstein L.P.3.5%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-24BlackRock, Inc.7.8%SCHEDULE 13G/A
2026-04-30Vanguard Capital Management7.49%SCHEDULE 13G
2026-05-15Fundsmith LLP4.4%SCHEDULE 13G/A
DateRecordFigureOur pageSource
August 21, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

All 5%+ stakes

RSS